GlassScriptPhysician profile
Shane Eugene Holloway
NPI 1043319940
$2,503.72
in general payments reported to CMS, 2019-2025
22 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $131 · 2021: $330 · 2022: $397 · 2023: $311 · 2024: $192 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682 · Travel and Lodging: $189 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $682.12 |
| Travel and Lodging | $188.85 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $703.39 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $318.14 | 2021-2025 | Myrisk |
| Intuitive Surgical, INC. | $306.12 | 2022-2025 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $278.09 | 2019-2025 | Stravix, Pico 7, Oasis |
| Medtronic, INC. | $218.69 | 2024-2025 | Progrip, Abre, Ligasure |
| Ethicon US, LLC | $114.29 | 2022-2024 | Ethicon, Echelon; Endopath, Enseal X1 |
| Baudax Bio INC. | $100.55 | 2021-2022 | |
| Conmed Corporation | $86.13 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Abbott Laboratories | $53.20 | 2023 | Jeti Peripheral Catheter |
| Vertex Pharmaceuticals Incorporated | $48.03 | 2024-2025 | |
| Acell, INC. | $46.02 | 2019-2020 | |
| Davol INC. | $31.67 | 2021 | |
| W. L. Gore & Associates, INC. | $24.31 | 2021 | |
| Shire North American Group INC | $17.94 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $16.86 | 2024 | Codman Hakim, Cusa Clarity, Codman Certas |
| Bioventus LLC | $16.78 | 2022 | |
| Cook Medical LLC | $15.26 | 2019 | |
| Kci USA, INC. | $11.91 | 2019 | |
| Merck Sharp & Dohme LLC | $11.84 | 2021 | |
| Lifenet Health | $10.03 | 2023 | |
| Bolder Surgical LLC | $5.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Holloway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.